Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis.
Jayne
David R W
DR
Department of Medicine, Addenbrooke's Hospital, Cambridge, UK. dj106@cam.ac.uk
D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology; D008727:Methotrexate / Q000627:therapeutic use; D008833:Microcirculation; D055502:Secondary Prevention; D016896:Treatment Outcome; D014657:Vasculitis / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate